Acting as an “AI biologist,” the platform analyses complex biological, clinical, and experimental datasets to help scientists test hypotheses, identify promising therapeutic pathways, and make faster go/no-go decisions.
Meta-Flux has raised €1.8M across 1 funding round from 1 investor, most recently a Seed round in Oct 2025. Based in Dublin, Ireland; active in Software. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-13 | Seed | €1.8M |
| senior executives |
| View deal → |
